Search     Contact 
     Members Sign-in 
ABOUT BAYBIOGET INVOLVEDEVENT CENTER





MEMBER CENTERINFORMATION CENTERMEDIA CENTERCAREER CENTER

Therapeutic Breakfast Series - First to Market: Bonus or Burden?

First-to-market is an essential strategy for many companies given the bonus of considerable return on investment: the market leader status as well as a gain of market share. On the opposite side of this strategy are companies that prefer to follow in someone else’s footsteps with less financial burden and a greater potential for success. After all, quite a few of the first-to-market companies have crashed and burned. The road to the first product on the market is tumultuous: there is pressure from venture capitalists, scientific and technical challenges to overcome, plenty of unknowns about the market, the costs and the reimbursement issues, as well as a threat of competitors closely behind with a cheaper and better product. Join a panel of industry professionals for a discussion of both strategies as well as lessons learned.

Moderator: Emily Hua
Vice President, Brand Management Practice, Campbell Alliance
Panel Speakers: Richard Clark
Sr. Director
Commercial Operations
ARYx Therapeutics, Inc.
Daniel Dornbusch
Business Development and Strategic Operations
Novartis Diagnostics
Sandra Shpilberg
Senior Director of Marketing
Business Development
BioMarin Pharmaceutical, Inc.
What: Therapeutic Breakfast Series
First-to-Market: Bonus or Burden?
When: September 24, 2009
8:00 - 10:00am
Where: Theravance, Inc.
901 Gateway Blvd.
South San Francisco, CA, 94080
Directions
Parking: Free parking
Attire: Business attire suggested
Cost: Early Bird Registration through Sept. 23:
$10.00 - BayBio Members
$20.00 - Non-Members

On-Site Registration, Sept. 24:
$20.00 - BayBio Members
$40.00 - Non-Members
 
Registration
(If you are an employee of a Partner or Sponsor company, please contact
Program Director, Misha Tsirulnikov to obtain your complimentary registration.)
Online Registration
Mail or Fax Registration
  • Pre-registered attendees will receive an immediate receipt/confirmation after submission.
  • Please print this receipt/confirmation and bring it with you to receive your conference credentials.
  • Photo ID (driver's license or passport) will be required at check-in.
  • All sales are final - BayBio offers no refunds

Please mail your event-related questions to: events@baybio.org or you can contact us via phone: 650-871-7101.

Is your company a member? Click here to check.
See how your company can save money by becoming a BayBio member!

Therapeutics Series Sponsors

Partners

Alexandria Real Estate Equities Amgen Baxter Biospace
Burr Pilger Mayer Burrill and Company Cooley Godward Kronish Deloitte Touche Tohmatsu
Ernest & Young FedEx Fenwick & West Genencor International
Genentech Gilead KPMG Latham and Watkins
Life Technologies Morrison & Foerster Nektar Oracle Life Sciences
Pfizer Roche RoseRyan Schwartz Communications
Technology Vision Group VWR Wareham Development Wells Fargo
BayBio 400 Oyster Point Blvd. Suite 221 South San Francisco CA 94080 Tel: (650) 871-7101